Snowball logo
logo
1099

Sinopharm Group Co. Ltd

HK$15.34-HK$0.06Β  (0.39%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
521,051.2552,147.6596,569.6584,507.9575,167.91,143,845
COGS
477,000.6504,713.5548,057.9540,252.5533,495.91,060,844.4
Gross Profit
44,050.647,434.148,511.744,255.441,67283,000.5
Operating Expenses & Income
Operating Income
19,71220,604.520,209.216,188.416,038.231,866.6
Total Operating Expenses
24,338.626,829.628,302.528,06725,633.851,133.9
R&D Expenses
-----123.4
Selling General & Admin Expenses
7,7618,183.68,678.18,413.57,837.611,941.3
Earnings from Continuing Operations
Interest Expense
(3,756.8)(3,520.3)(2,956.6)(2,734)(2,300.1)(3,777.1)
Interest Income
2,092.91,886.6743.41,003.6582.91,244.2
Income Tax Expense
3,938.44,218.44,502.33,577.33,965.27,583
Net Income
Net Income
7,758.68,525.79,053.87,049.77,155.113,849.7
Supplemental
EBIT
20,76022,084.122,468.717,819.117,229.634,831.5
EBITDA
24,682.126,249.226,89922,558.721,518.643,481.6
In millions of HKD, except % and values per 1 share